Mind Medicine Inc (MNMD NASDAQ) stock market data APIs
$6.6317
-0.15(-2.3%)
as of July 1, 2025
Try our APIs with
free plan!
Mind Medicine Inc Financial Data Overview
Price chart is built with
Anychart
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.
Prev. Close
6.6317
Open
6.4833
High
6.9219
Low
6.4497
52 wk Range
4.7-10.4362
Market Cap
490 M
Shares Outstanding
75 553 K
EPS
-0.35
Beta
2.884
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Mind Medicine Inc data using free add-ons & libraries
Get Mind Medicine Inc Fundamental Data
Mind Medicine Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -114 364 248
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-06
- EPS/Forecast: -0.53
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Mind Medicine Inc News
New
Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032
PALM BEACH, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Worldwide, there is a rising demand for neuropsychiatric disorder treatments which is expected to fuel the global...
Mind Medicine at H.C. Wainwright: Strategic Advances in Neuropsychiatry
On Tuesday, 17 June 2025, Mind Medicine (NASDAQ:MNMD) presented at the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference. The company, led by CEO Rob Barrow, highlighted its strategic fo...
Why Mind Medicine Gave Investors a Powerful Buzz in May
Key Points Connecticut lawmakers advanced a bill that would decriminalize psilocybin if ultimately passed. Investors were also cheered by a C-suite appointment. 10 stocks we like better than Mind Med...
Mind Medicine (MindMed) Inc. (MNMD): Analysts See 285% Upside Potential
We recently published an article titled 13 Best Multibagger Stocks to Invest in Now. Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) was one of the stocks that was covered in that article. Wall Street anal...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
